Zoekresultaten - 3 results
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
order to guide decisions on DAA reimbursement. METHODS: Residual sera were collected through clinical laboratories. We collected data on age, sex and district. HCV antibody status was determined with ...
Distribution of HCV genotypes in Belgium from 2008 to 2015.
However they are outdated, lack nationwide representativeness or were not conducted in the general population. METHODS: In order to determine the distribution of different circulating HCV genotypes in ...
Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method
on data from more than fifteen years ago and apply only to those who report ever injecting drugs. As a result, no reliable baseline data exist to determine the scale of services for PWID. Methods We ...